Dr. Shripad Suryakant Pujari

MBBS, M.D. (Med), D.M. (Neuro), DNB (Neuro), MRCP (London)

Head of Department

Department of Neurology

Areas of Expertise:

  • Multiple sclerosis, NMOSD, neuroimmunology
  • Neuro-infections
  • Neurology of COVID

Qualifications:

MBSS (1992)
BJ Medical College, Pune, Maharashtra

MD Medicine (1997)
Sassoon General Hospital, Pune, Maharashtra

DM Neurology (2001)
Grant Medical College and Sir JJ Group of Hospitals, Mumbai, Maharashtra

FRCP (2005)
Royal College of Physicians, London

Years of Experience:

21 Years

Languages:

English, Marathi, Hindi

Additional Information:

  • Performed basic science research on cytokines and lymphocytes on multiple sclerosis during his stay in the UK.
  • Holds positions of Secretary of Neuro Society of Pune and Maharashtra Association of Neurology.

Awards and Achievements:

  • Distinction in ENT
  • Best paper award in the International Tropical Neurology Conference

Publications:

  • A longitudinal study to assess plasma fractalkine levels in patients with relapsing remitting multiple sclerosis. Pujari S, Suliman O, Sharrack B et al. Neurology; 2007; 68 (12- suppl 1): a17.
  • Pujari SS, Kulkarni RV, Nadgir DB, Ojha PK, Nagendra S, Aglave V, et al. Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome. Ann Indian Acad Neurol. 2021 Jan-Feb;24(1):69-77. doi: 10.4103/aian.AIAN_627_19.
  • Pujari SS, Kulkarni PS, Kulkarni RV. Chemotherapy-induced peripheral neuropathy: Current status and future directions. Indian J Med Paediatr Oncol. 2021 Feb 07. DOI: 10.4103/ijmpo.ijmpo_158_20 [Epub ahead of print]
  • Kulkarni RV, Pujari SS, et al. COVID-19 and acute ischemic stroke; an Indian experience. Ann Indian Acad Neurol. 2020 Oct 15. DOI: 10.4103/AIAN.AIAN_897_20 [Epub ahead of print]
  • Kulkarni RV, Pujari SS, et al. Rhino-orbito-cerebral mycosis and COVID-19: from bad to worse? Ann Indian Acad Neurol. 2021 Aug 20. DOI: 10.4103/AIAN.AIAN_463_21 [Epub ahead of print]
  • Kulkarni RV, Pujari SS et al. Neurological manifestations of Dengue fever. Ann Indian Acad Neurol. 2021 May 31. DOI: 10.4103/aian.AIAN_157_21 [Epub ahead of print]
  • Pujari SS, Kulkarni RV et al. Neurosyphilis, A true chameleon of Neurology. Ann Indian Acad Neurol. 2021 Jun 17. DOI: 10.4103/aian.AIAN_28_21 [Epub ahead of print]
  • Ojha PT, Nagendra S, Pujari SS et al. DWI-FLAIR Mismatch-guided IVT is Safe and Effective in Treatment of AIS Beyond 4.5 Hours. Journal of Stroke Medicine 2020;3(2):81-87.
  • Alurkar A, Amin R, Divate P, Doshi S, Das S, Ichaporia N, Kulkarni R, Nirhale S, Pujari S, et al. An epidemiological case control multi-centre trial on Cerebral Venous Sinus Thrombosis in Western Maharashtra, India. J Assoc Physicians India 2021 Sep;69:32-6.
  • Acute hemorrhagic leucoencephalitis (AHLE) - A rare variant of ADEM. S. Pujari, R. Kulkarni. J Neurol Sci 2019. doi:10.1016/j.jns.2019.10.1134
  • Anti-musk antibody myasthenia gravis: Clinical findings and long term follow up. R. Kulkarni, S. Pujari. J Neurol Sci 2019. doi:10.1016/j.jns.2019.10.1267
  • Gullain Barre syndrome and dengue fever R. Kulkarni, S. Pujari J Neurol Sci 2019. doi:10.1016/j.jns.2019.10.1096
  • Etiological spectrum of optic neuropathies: a retrospective study of 58 cases. S. Pujari, D. Nadgir, R. Nadgir, R. Kulkarni. J Neurol Sci 2019.
  • UNIQUE PRESENTATIONS OF MOG ASSOCIATED DEMYELINATING DISEASE. PUJARI S, KULKARNI R, OJHA P ET AL. EUR J NEUROL. 2019; VOL 26 (JUL), SUPPL S1: 901-902.
  • OUR EXPERIENCE WITH RITUXIMAB IN CHRONIC RELAPSING NEUROLOGICAL DISEASES. NIRHALE S, PUJARI S, KULKARNI R ET AL. EUR J NEUROL. 2019; VOL 26 (JUL), SUPPL S1: 898.
  • FATE OF PATIENTS WHO PRESENT WITH OPTIC NEURITIS. NADGIR D, PUJARI S, KULKARNI R ET AL. EUR J NEUROL. 2019; VOL 26 (JUL), SUPPL S1: 711.
  • MOG ANTIBODY ASSOCIATED DEMYELINATING DISEASES: OUR EXPERIENCE. KADDU D, KULKARNI R, PUJARI S. ANN INDIAN ACAD NEUROL 2018;21(6):S180.
  • MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG) ANTIBODIES IN NEUROLOGY: A REVIEW. PUJARI S, KULKARNI R. YEARBOOK NEUROLOGY (IAN). 2018.
  • CLINICAL PROFILE AND TREATMENT PATTERN OF NMOSD IN INDIA. PUJARI S, KULKARNI R, NIRHALE S ET AL. EUR J NEUROL. 2018; VOL 25 (JUN), SUPPL S2: 191.
  • CEREBRAL ABSCESSES AS A PRESENTATION OF NOCARDIOSIS IN 3 IMMUNOCOMPROMISED PATIENTS. PUJARI S, KULKARNI R, MELINKERI S, PURANDARE B. ANN INDIAN ACAD NEUROL 2017; 20(5):S18.
  • PERSISTING TUBERCULOMAS: WHEN TO STOP THERAPY? KULKARNI R, PUJARI S, ATRE A. ANN INDIAN ACAD NEUROL 2017; 20(5):S8.
  • CHIKUNGUNYA ENCEPHALITIS AND “DIFFUSION DOT SIGN’’. JAGTAP S, KULKARNI R, PUJARI S, JOSHI A. ANN INDIAN ACAD NEUROL 2017; 20(5):S14.
  • INCIDENCE OF NEUROLOGICAL COMPLICATIONS IN PATIENTS SUFFERING FROM DENGUE IN TWO SPECIALTY HOSPITALS FROM WESTERN INDIA. PALASDEOKAR N, RAHUL K, SHRIPAD P, MUKUND V, SUJIT J, DILEEP M. ANN INDIAN ACAD NEUROL 2017; 20(5):S18.
  • ATYPICAL PRESENTATION OF HERIDITORY SENSORY AUTONOMIC NEUROPATHY(HSAN) TYPE 2. ANNALS OF IAN, SEPTEMBER,2001.